Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $0.8016 per EA under NDC 51991007301. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jun 10, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP
Butalbital, Acetaminophen, Caffeine and Codeine PhosphateStrength
325; 50; 40; 30 mg/1; mg/1; mg/1; mg/1
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991007301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA076560FDA Approved
6/10/2004
TE Code
AB
On Market Since
7/1/2004
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 222.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8016 per EA |
|---|---|
| All-time high | $1.1376 (Aug 12, 2015) |
| All-time low | $0.2490 (Nov 28, 2013) |
| 52-week high | $0.9086 |
| 52-week low | $0.7990 |
| Median price | $0.8928 |
| Average price | $0.8662 |
| Largest weekly change | +45.9% (Jul 23, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP, manufactured by Breckenridge Pharmaceutical Inc., is $0.8016 per EA (NDC 51991007301), effective Aug 19, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP has risen 222.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?
Since Nov 28, 2013, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP has ranged from a low of $0.2490 (Nov 28, 2013) to a high of $1.1376 (Aug 12, 2015), with a median of $0.8928 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP (NDC 51991007301) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.